Table 2.
Average weekly prevalence (with 95% confidence intervals) during the 30-week observation period of all health problems and substantial health problems reported, as well as for subcategories of illness, acute and overuse injury in each subgroup of sex and disciplines.
| All athletes | Male athletes | Female athletes | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Total | Endurance | Explosive | Total | Endurance | Explosive | Total | Endurance | Explosive | |
| Athletes [n (%)] | 70 (100.0) | 25 (35.7) | 45 (64.3) | 37 (52.9) | 19 (27.1) | 18 (25.7) | 33 (47.1) | 6 (8.6) | 27 (38.6) |
| Response rate [mean (SD)] | 71.3 (11.6) | 64.4 (12.5) | 75.1 (11.6) | 69.2 (11.6) | 63.0 (13.3) | 75.9 (10.4) | 73.6 (12.5) | 69.0 (15.3) | 74.6 (13.4) |
| All health problems | 27.3 (16.9 to 37.8) | 32.7 (21.7 to 43.7)* | 24.7 (14.6 to 34.9)* | 25.6 (15.4 to 35.8) | 27.4 (16.9 to 37.8)$ | 24.2 (14.2 to 34.2) | 29.0 (18.4 to 39.6) | 47.1 (35.4 to 58.8)$* | 25.2 (15.0 to 13.0)* |
| Illness | 6.8 (0.9 to 12.7) | 6.9 (0.9 to 12.8) | 6.8 (0.9 to 12.7) | 5.6 (0.2 to 11.0) | 5.8 (0.3 to 11.2) | 5.6 (0.2 to 11.0) | 8.0 (1.6 to 14.3) | 8.9 (2.2 to 15.5) | 7.6 (1.4 to 13.9) |
| Injury | 20.5 (11.0 to 30.0) | 25.9 (15.6 to 36.1)* | 17.9 (8.9 to 26.9)* | 20.0 (10.6 to 29.3) | 21.6 (12.0 to 31.3)$ | 18.6 (9.5 to 27.7) | 21.0 (11.5 to 30.6) | 38.3 (26.9 to 49.7)$* | 17.5 (8.6 to 26.5)* |
| Acute injury | 7.5 (1.3 to 13.7) | 4.3 (−0.5 to 9.0)* | 9.0 (2.3 to 15.7)* | 7.5 (1.3 to 13.6) | 5.5 (0.1 to 10.8) | 9.3 (2.5 to 16.1) | 7.4 (1.3 to 13.6) | 0.9 (−1.3 to 3.0)* | 8.8 (2.2 to 15.5)* |
| Overuse injury | 13.0 (5.1 to 20.9) | 21.6 (12.0 to 31.2)* | 9.0 (2.3 to 15.6)* | 12.5 (4.8 to 20.3) | 16.2 (7.5 to 24.8)$* | 9.3 (2.5 to 16.1)* | 13.6 (5.6 to 21.6) | 37.4 (26.1 to 48.7)$* | 3.9 (−0.6 to 8.4)* |
| Substantial health problems | 10.6 (3.4 to 17.8) | 17.6 (8.7 to 26.6)* | 7.4 (1.3 to 13.5)* | 11.3 (3.9 to 18.7) | 15.6 (7.1 to 24.1)* | 8.0 (1.6 to 14.3)* | 9.8 (2.8 to 16.8) | 22.8 (13.0 to 32.6)* | 7.0 (1.0 to 13.0)* |
| Illness | 2.1 (−1.3 to 5.4) | 2.1 (−1.3 to 5.4) | 2.1 (−1.3 to 5.5) | 2.2 (−1.2 to 5.7) | 1.8 (−1.3 to 5.0) | 2.7 (−1.1 to 6.6) | 1.9 (−1.3 to 5.1) | 2.6 (−1.1 to 6.3) | 1.8 (−1.3 to 4.8) |
| Injury | 8.4 (1.9 to 14.9) | 15.4 (6.9 to 23.8)* | 5.1 (0.0 to 10.3)* | 9.2 (2.4 to 15.9) | 13.6 (5.5 to 21.6)* | 5.6 (0.2 to 11.0)* | 7.5 (1.3 to 13.7) | 20.2 (10.8 to 29.6)* | 4.8 (−0.2 to 9.8)* |
| Acute injury | 3.4 (−0.9 to 7.6) | 2.6 (−1.1 to 6.3) | 3.7 (−0.7 to 8.2) | 3.5 (−0.8 to 7.7) | 3.5 (−0.8 to 7.8) | 3.5 (−0.8 to 7.8) | 3.2 (−0.9 to 7.3) | 0.0 (0.0 to 0.0) | 3.9 (−0.6 to 8.4) |
| Overuse injury | 5.0 (−0.1 to 10.1) | 12.8 (5.0 to 20.7)* | 1.4 (−1.4 to 4.2)* | 5.7 (0.3 to 11.2) | 10.1 (3.0 to 17.1)$* | 2.1 (−1.3 to 5.5)* | 4.3 (−0.4 to 9.1) | 20.2 (10.8 to 29.6)$* | 0.9 (−1.3 to 3.1)* |
$
Significant difference between male and female athletes.
*
Significant difference between endurance and explosive disciplines.